CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Alzheimer’s Disease: Current Treatments and Potential New Agents
Current research focuses on agents that target secretase enzymes to prevent plaque accumulation.
Applying HIV/AIDS Lessons to the Opioid Crisis
Successful programs feature a mix of social and scientific components.
An Overview of Naloxone for Pharmacists
The most common medications involved in prescription-opioid overdose deaths include methadone, oxycodone, and hydrocodone.
Prescribed Opioids Raise Pneumonia Risk
Opioid-related research developments of interest to pharmacists.
Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.